|
PEX26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.001600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.160600E-04 |
| Normal-vs-Stage2 |
1.263570E-01 |
| Normal-vs-Stage3 |
1.781699999992E-05 |
| Normal-vs-Stage4 |
2.603800E-04 |
| Stage1-vs-Stage2 |
2.330600E-01 |
| Stage1-vs-Stage3 |
1.672410E-01 |
| Stage1-vs-Stage4 |
3.836800E-01 |
| Stage2-vs-Stage3 |
6.530100E-02 |
| Stage2-vs-Stage4 |
1.162040E-01 |
| Stage3-vs-Stage4 |
8.707800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.156240E-04 |
| Normal-vs-AfricanAmerican |
2.039200E-01 |
| Normal-vs-Asian |
1.035080E-03 |
| Caucasian-vs-AfricanAmerican |
1.973610E-01 |
| Caucasian-vs-Asian |
7.133200E-01 |
| AfricanAmerican-vs-Asian |
2.051000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.18030000000469E-05 |
| Normal-vs-Female |
6.042200E-04 |
| Male-vs-Female |
1.535960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.021600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.181800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.564400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.799600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.029000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.643200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.928400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.385600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.107800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.890400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.943020E-01 |
| Classical-VS-Follicular |
2.335200E-01 |
| Classical-VS-Other |
1.036990E-01 |
| Classical-VS-Normal |
1.443930E-03 |
| Tall-VS-Follicular |
7.362800E-01 |
| Tall-VS-Other |
3.215400E-01 |
| Tall-VS-Normal |
4.961700E-04 |
| Follicular-VS-Other |
3.684600E-01 |
| Follicular-VS-Normal |
5.244100E-04 |
| Other-VS-Normal |
3.762500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.4304000000035E-05 |
| Normal-vs-N1 |
3.67580000000256E-05 |
| N0-vs-N1 |
1.372210E-01 |
|
|
